Search alternatives:
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
19621
Supplementary Material for: Atypical COVID-19-related Acute Macular Neuroretinopathy with Progression resulting in Severe Vision Loss
Published 2024“…Introduction: We review the clinical course of a patient with decreased vision in the setting of COVID-19 infection consistent with an atypical presentation of acute macular neuroretinopathy (AMN). …”
-
19622
Dynamics of pericytes in the HUVEC-pericyte coculture system.
Published 2020“…Scale bars: 500 μm (a–g); 100 μm (h–k).</p>…”
-
19623
Supplementary Material for: Newborn Resuscitation Training Programmes Reduce Early Neonatal Mortality
Published 2016“…Decreasing trends were noted for late neonatal mortality [RR 0.47 (95% CI 0.20-1.11)] and perinatal mortality [RR 0.94 (95% CI 0.87-1.00)], but there were no differences in fresh stillbirths [RR 1.05 (95% CI 0.93-1.20)]. …”
-
19624
Systemic antioxidant treatment and intermittent fasting delay axonal degeneration in mice.
Published 2013“…The neurofilament signal decrease progressively at 3, 5 and 7 days after nerve injury in non-treated mice (A). …”
-
19625
PRISMA flow-chart of the study selection process.
Published 2023“…Meta analysis results showed that, compared with conventional western medicine alone, STS combined with conventional western medicine could reduce the frequency (SMD = -2.61, 95%CI[-4.27, -0.96], <i>P</i> = 0.002) and duration (SMD = -4.01, 95%CI[-6.18, -1.84], <i>P</i> = 0.0003) of angina pectoris, improve ECG efficacy (OR = 3.61, 95%CI[2.79, 4.68], <i>P<</i>0.00001) and clinical symptom efficacy (OR = 4.02, 95%CI[3.32, 4.87], <i>P<</i>0.00001), reduce TG(SMD = -0.60, 95%CI[-1.04, -0.16], <i>P</i> = 0.008), TC(SMD = -3.86, 95%CI[-6.37, -1.34], <i>P</i> = 0.003), and LDL-C(SMD = -1.54, 95%CI[-2.67, -0.42], <i>P</i> = 0.007), decrease plasma viscosity(SMD = -1.02, 95%CI[-1.58, -0.47], <i>P<</i>0.0003), whole blood low shear viscosity(SMD = -0.85, 95%CI[-1.21, -0.49], <i>P<</i>0.00001), whole blood high shear viscosity(SMD = -0.82, 95%CI[-1.44, -0.20], <i>P</i> = 0.009), and erythrocyte aggregation index(SMD = -1.00, 95%CI[-1.75, -0.25], <i>P</i> = 0.009), and bring down CRP(SMD = -1.39, 95%CI[-1.91, -0.86], <i>P</i><0.00001). …”
-
19626
Bias risk assessment for individual studies.
Published 2023“…Meta analysis results showed that, compared with conventional western medicine alone, STS combined with conventional western medicine could reduce the frequency (SMD = -2.61, 95%CI[-4.27, -0.96], <i>P</i> = 0.002) and duration (SMD = -4.01, 95%CI[-6.18, -1.84], <i>P</i> = 0.0003) of angina pectoris, improve ECG efficacy (OR = 3.61, 95%CI[2.79, 4.68], <i>P<</i>0.00001) and clinical symptom efficacy (OR = 4.02, 95%CI[3.32, 4.87], <i>P<</i>0.00001), reduce TG(SMD = -0.60, 95%CI[-1.04, -0.16], <i>P</i> = 0.008), TC(SMD = -3.86, 95%CI[-6.37, -1.34], <i>P</i> = 0.003), and LDL-C(SMD = -1.54, 95%CI[-2.67, -0.42], <i>P</i> = 0.007), decrease plasma viscosity(SMD = -1.02, 95%CI[-1.58, -0.47], <i>P<</i>0.0003), whole blood low shear viscosity(SMD = -0.85, 95%CI[-1.21, -0.49], <i>P<</i>0.00001), whole blood high shear viscosity(SMD = -0.82, 95%CI[-1.44, -0.20], <i>P</i> = 0.009), and erythrocyte aggregation index(SMD = -1.00, 95%CI[-1.75, -0.25], <i>P</i> = 0.009), and bring down CRP(SMD = -1.39, 95%CI[-1.91, -0.86], <i>P</i><0.00001). …”
-
19627
Subgroup analysis of angina pectoris attack time.
Published 2023“…Meta analysis results showed that, compared with conventional western medicine alone, STS combined with conventional western medicine could reduce the frequency (SMD = -2.61, 95%CI[-4.27, -0.96], <i>P</i> = 0.002) and duration (SMD = -4.01, 95%CI[-6.18, -1.84], <i>P</i> = 0.0003) of angina pectoris, improve ECG efficacy (OR = 3.61, 95%CI[2.79, 4.68], <i>P<</i>0.00001) and clinical symptom efficacy (OR = 4.02, 95%CI[3.32, 4.87], <i>P<</i>0.00001), reduce TG(SMD = -0.60, 95%CI[-1.04, -0.16], <i>P</i> = 0.008), TC(SMD = -3.86, 95%CI[-6.37, -1.34], <i>P</i> = 0.003), and LDL-C(SMD = -1.54, 95%CI[-2.67, -0.42], <i>P</i> = 0.007), decrease plasma viscosity(SMD = -1.02, 95%CI[-1.58, -0.47], <i>P<</i>0.0003), whole blood low shear viscosity(SMD = -0.85, 95%CI[-1.21, -0.49], <i>P<</i>0.00001), whole blood high shear viscosity(SMD = -0.82, 95%CI[-1.44, -0.20], <i>P</i> = 0.009), and erythrocyte aggregation index(SMD = -1.00, 95%CI[-1.75, -0.25], <i>P</i> = 0.009), and bring down CRP(SMD = -1.39, 95%CI[-1.91, -0.86], <i>P</i><0.00001). …”
-
19628
Meta-analysis off requency of angina attacks.
Published 2023“…Meta analysis results showed that, compared with conventional western medicine alone, STS combined with conventional western medicine could reduce the frequency (SMD = -2.61, 95%CI[-4.27, -0.96], <i>P</i> = 0.002) and duration (SMD = -4.01, 95%CI[-6.18, -1.84], <i>P</i> = 0.0003) of angina pectoris, improve ECG efficacy (OR = 3.61, 95%CI[2.79, 4.68], <i>P<</i>0.00001) and clinical symptom efficacy (OR = 4.02, 95%CI[3.32, 4.87], <i>P<</i>0.00001), reduce TG(SMD = -0.60, 95%CI[-1.04, -0.16], <i>P</i> = 0.008), TC(SMD = -3.86, 95%CI[-6.37, -1.34], <i>P</i> = 0.003), and LDL-C(SMD = -1.54, 95%CI[-2.67, -0.42], <i>P</i> = 0.007), decrease plasma viscosity(SMD = -1.02, 95%CI[-1.58, -0.47], <i>P<</i>0.0003), whole blood low shear viscosity(SMD = -0.85, 95%CI[-1.21, -0.49], <i>P<</i>0.00001), whole blood high shear viscosity(SMD = -0.82, 95%CI[-1.44, -0.20], <i>P</i> = 0.009), and erythrocyte aggregation index(SMD = -1.00, 95%CI[-1.75, -0.25], <i>P</i> = 0.009), and bring down CRP(SMD = -1.39, 95%CI[-1.91, -0.86], <i>P</i><0.00001). …”
-
19629
Meta-analysis of angina pectoris attack time.
Published 2023“…Meta analysis results showed that, compared with conventional western medicine alone, STS combined with conventional western medicine could reduce the frequency (SMD = -2.61, 95%CI[-4.27, -0.96], <i>P</i> = 0.002) and duration (SMD = -4.01, 95%CI[-6.18, -1.84], <i>P</i> = 0.0003) of angina pectoris, improve ECG efficacy (OR = 3.61, 95%CI[2.79, 4.68], <i>P<</i>0.00001) and clinical symptom efficacy (OR = 4.02, 95%CI[3.32, 4.87], <i>P<</i>0.00001), reduce TG(SMD = -0.60, 95%CI[-1.04, -0.16], <i>P</i> = 0.008), TC(SMD = -3.86, 95%CI[-6.37, -1.34], <i>P</i> = 0.003), and LDL-C(SMD = -1.54, 95%CI[-2.67, -0.42], <i>P</i> = 0.007), decrease plasma viscosity(SMD = -1.02, 95%CI[-1.58, -0.47], <i>P<</i>0.0003), whole blood low shear viscosity(SMD = -0.85, 95%CI[-1.21, -0.49], <i>P<</i>0.00001), whole blood high shear viscosity(SMD = -0.82, 95%CI[-1.44, -0.20], <i>P</i> = 0.009), and erythrocyte aggregation index(SMD = -1.00, 95%CI[-1.75, -0.25], <i>P</i> = 0.009), and bring down CRP(SMD = -1.39, 95%CI[-1.91, -0.86], <i>P</i><0.00001). …”
-
19630
CORM-2 and tobramycin have additive effects on PAO1 biofilm formation.
Published 2012“…<p>A) CORM-2 (100 µM) is as effective as tobramycin (1 mg/ml) in decreasing the biomass of the bacterial biofilm after 6 hours treatment, as measured by CV staining and the combination is better than either alone. …”
-
19631
Incubation of NE increased number of AP evoked by ramp current stimulation.
Published 2014“…(C, D, E) Time to first peak (TTFP) of AP in response to 100 pA (C, *p<0.05, compared with Pre), 300 pA (D,*p <0.05, compared with Pre) and 500 pA ramp current stimulation (E, *p<0.05, compared with Pre) was significantly decreased after NE incubation.…”
-
19632
Effect of TAF273 on cell cycle distribution in K-562 cells treated for 72 h.
Published 2014“…<p>The flow cytometry analysis of PI-labeled cells indicates that treatment of K-562 cells with 25 µg/ml of TAF273 for 72 h led to increase in the G1 population from 24.34% in the control cells to 40.48% in treated cells. In mean time, the S and G2 populations decreased from 61.98% and 13.68% in the control cells to 40.48% and 6.93% in treated cells, respectively. …”
-
19633
Lysosomal translocation of GAPDH-HT reflects CMA activity in HeLa cells.
Published 2012“…The percentage of GAPDH-HT dot-positive cells and the number of GADPH-HT dots per cell were significantly decreased by siRNA-mediated LAMP2A-knockdown. ** p<0.001 vs cells treated with nontargeting-siRNA (unpaired <i>t</i>-test, n = 16 in <i>B</i>, n = 57 for nontargeting-siRNA and n = 74 for LAMP2A-siRNA in <i>C</i>). …”
-
19634
-
19635
C2CD3 regulates spatial organization of centriole architecture.
Published 2025“…For CEP162-positive centrioles: siCTRL = 100% ± 0, siC2CD3 = 50.83% ± 4.31. Overall CEP162 fluorescence decreased in siC2CD3 (<i>n</i> = 31, 1.47 ± 0.39 AU.) vs. siCTRL (<i>n</i> = 35, 1.68 ± 0.51 AU), unpaired <i>t</i> test *** <i>P</i> value = 0.0008. …”
-
19636
The effect of species divergence time on divergence-based ascertainment bias.
Published 2013“…The strength of a divergence-based ascertainment bias decreases as a function of species divergence time, but does very slowly such that an appreciable effect remains at species divergence times of 100.…”
-
19637
Effect of mCPP on insulin secretion from pancreatic β-cells.
Published 2013“…<p>A: After treatment with 1 to 100 µmol/l mCPP for 12 h, insulin secretion from Min-6 cells under stimulus of 16.7 mM glucose decreased in a mCPP dose-dependent manner (n = 6; <sup>*</sup><i>P</i><0.05; <sup>**</sup><i>P</i><0.01). …”
-
19638
Pharmacologic inhibition of YAP inhibits tumor growth <i>in vivo</i>.
Published 2015“…<p><b>(A)</b> SMS-CTR cells treated with 10μM VP have decreased cell growth, measured by manual cell counting over five days. …”
-
19639
Effect of the MRP on the accumulated number of infected nodes.
Published 2016“…<p>When the disease can be transmitted only through the trade network (green line), the MRP is a very efficient tool to stop the spreading of the disease. …”
-
19640
Kinetics of PI(3,4,5)P3 hydrolysis by PTEN at different concentrations of YFP-PHGrp1.
Published 2018“…<p>(A) The membrane composition is 0.2% PI(3,4,5)P3 + 5% DOPS + 0.2% PI(4,5)P2 + 94.4% DOPC + 0.2% TR-DHPE and the bulk concentration of YFP-PHGrp1 is 100 nM (square), 150 nM (circle), 300 nM (triangle), and 600 nM (down-pointing triangle), respectively. …”